Conrad En Zuo Chan

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye et al. · PLoS ONE · 2021 · 106 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia

Daniel Asarnow, Bei Wang, Wen-Hsin Sandy Lee et al. · Cell · 2021 · 82 citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays

Conrad En Zuo Chan, Annie HY Chan, Angeline Lim et al. · Journal of Immunological Methods · 2011 · 50 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells

Hae-Young Park, Peck Szee Tan, Ranmali Kavishna et al. · npj Vaccines · 2017 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

<scp>IDentif</scp> . <scp>AI</scp> : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

Agata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah et al. · Bioengineering & Translational Medicine · 2020 · 44 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16